Thomsen Bioscience close to breakthrough  

2004.03.01
The Northern Jutland based biotech company is currently negotiating with several foreign governments on sales of a detection system for biodefence

Biotech company Thomsen Bioscience is currently negotiating with several foreign governments on sales of a detection system for biodefence. Thomsen Bioscience has developed a Biological Warfare Agent Detection Chip (BWAC), a portable device which can perform fully automated and unattended detection of biological warfare agents or airborne infectious diseases such as SARS. Lars Thomsen, managing director of Thomsen Bioscience, says he expects to make the first major government agreement in the near future.

 

Thomsen Bioscience is also close to a new round of financing. Fresh capital is needed to complete the development of the BWAC device which is planned for production in spring 2004. The company, founded 1st September 2001 – just 10 days before the terrorist attack on the World Trade Centre – is located in Norresundby in north Jutland. Neighbouring concern RTX Telecom has invested DKK 3 million (USD 510,000) in Thomsen Bioscience. The news is reported by BiotechDenmark online.

 

Link > Thomsen Bioscience 

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×